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Abstract
The discovery and ability to provide an absolute concentration of biomarkers in the body can
facilitate early diagnoses of diseases. This information can also be used for more accurate and
unique treatments for those patients. While major advances in molecular mass spectrometry
allows for a sensitive identification of these biomarkers, they are limited to only four orders of
magnitude in their dynamic ranges. Due to this, detection and quantitation of low abundant
proteins, which tend to make up these vital biomarkers, is very difficult. On the other hand, ICPMS offers a wider dynamic range (up to 12 orders of magnitude) for quantitation of most
metals. The goal of this work is to utilize metal (in particular, lanthanides) tagging to derivatize
proteins for ICP-MS measurement. In this study we will report the preliminary analytical
performance for a single quadrupole ICP-MS for the determination of lanthanides in solution as
well as the first derivatization step of the proteins – conjugating a metal chelator to a protein.
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Chapter 1 – Introduction
1.0 What is proteomics?
Proteins perform many important and life-dependent functions in cells, tissues, and organs of
organisms. Therefore, proteomics was developed to better characterize and identify the entire
set of proteins that make them up.1 Proteomics was developed to study the composition,
structure, function, and cellular interactions within an organism. The main goal, often, is to
unravel how the expression and quantity of proteins change under various conditions (e.g., if it
is normal vs. when it is diseased) and to understand how proteins function and interact within
the cell.1 This information is useful in many applications including, but not limited to
diagnostics/clinical (e.g., biomarker discovery or identification of emerging disease), agricultural
(e.g., plant-insect interactions to determine the defensive responses of plants to herbivores), or
food (e.g., biological and microbial safety of genetically modified foods). 2

However, proteomic analysis faces many challenges that can be categorized into the following
groups: (i) the suppression of the detection and quantitation of low abundance proteins (LAPs)
by high abundance proteins (HAPs), (ii) the detection and quantitation of transient species that
may appear under only certain conditions, (iii) the isolation of native forms of proteins that
denature easily and deeply once extracted, (iv) the search for effective technologies to analyze
isoforms that may result from post translational modifications, (v) the determination of low
abundance proteins in the complex proteome, and (vi) the improvement of the dynamic range
of analytical instruments.1 This project is focused on improving the dynamic range of analytical
methods to better enhance the detection and quantitation of low abundance proteins.
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Broadening the linear dynamic range of proteomic methods facilitates the opportunity to detect
and measure low abundance proteins in the presence of high abundance proteins. This will
reduce the need for removing the HAPs (e.g., via one of the protein depletion methods) and
concentrating LAPs (e.g., via one of the protein enrichment methods) prior to analysis. This is
important since some LAPs are lost during these processes.

1.1 Low Abundance Proteins
The human proteome is one of the most complex systems in biology. Each expressed gene in the
human proteome comes with over tens of hundreds of expressed protein variations, and posttranslational modifications. The number of coding genes are small and relatively fixed compared
to the numbers of proteins and dynamic range in the proteome. Many factors may contribute to
this and occur at various stages in the life cycle of the initial protein:
1) The same coding gene can mutate resulting in slightly different proteins
2) Each type of initially coded protein can undergo post-translational modification (PTMs),
for example glycosylation. Different types of glycosylation can result in as many as twenty
different glycosylated forms as well as cleaved variants of these forms. Other PTMs could
include phosphorylation, acylation, etc.
3) Differential expression of coding genes from tissue to tissue could occur causing the
concentrations of a type of protein to vary with time, type of cell, and cellular conditions.
This means that the protein composition of any one type of cell may differ from another
causing the composition to vary with time.
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For example, say a cell contains 1000 original proteins. If each of these proteins has around
twenty different glycosylated forms and around ten different cleaved variants the total protein
population adds up to around 200,000 in the proteome. This total proteome content does not
include any other post-translational modifications, isoforms, spliced variants, etc.1

To add to this complexity, the concentrations of these proteins can span over 10 to 12 orders of
magnitude.1,3 In a serum proteome, the total protein content consists of 90% of the top ten most
abundant proteins and the rest, or the low abundance proteins, are present in a very wide range
(up to 10 orders of magnitude in concentration).4 Although many important proteins are in high
abundance, their concentrations often mask other important proteins that are low in abundance
therefore making the discovery and quantitation of other vital proteins very difficult. 3 To better
represent the complexity of the proteome, and to distinguish “abundance” from
“concentration”, a hypothetical proteome is described by Table 1 and presented in Figure 1 for
clarity.
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Protein Type

Table 1. The distribution of proteins in a hypothetical proteome. “Protein Type” refers to the unmodified
protein and any post-translational modified proteins from that protein (e.g., glycosylated, acetylated, etc.),
“Protein Category” refers to a specific family of a protein (e.g., albumins, collagens, etc.)

Protein
Number of
Types
(Abundance)

1
2
3
4
5
6
7
8
9
10

Protein Categories and Concentration (mg/dL)
A
B
C
D
E
F
G
H
10
200
10 1000 23
100
28 2000
5
500 121 500
57
54
21
12
100 321 678
28
78
24
200 234 234
12
10
54
100
221 234
11
23
54
100 221
57
78
60
100
28
431
34
12
324
35
10

9

4

7

8

5

2

1

I
2
3

2

Figure 1. A plot of the distribution of proteins in the hypothetical proteome. “Protein Type” refers to the
unmodified protein and any post-translational modified proteins from that protein (e.g., glycosylated,
acetylated, etc.), “Protein Category” refers to a specific family of a protein (e.g., albumins, collagens, etc.)
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In this proteome, there are 47 types of proteins with the total abundance being 48 (100%). The
four high abundant groups (A, B, E, and D) account for 71% (34) of the proteome. The low
abundant groups (I, H, and G) account for only 10% (5). H1 is the protein with the highest
concentration. I1 and I2 have the lowest concentrations and are also in low abundance. One
example is albumin, a family of globular proteins that are often found in blood plasma and other
various proteomes differentiating them from other blood proteins. In serum, albumin proteins
are often considered of high abundance, putting them in this hypothetical proteome in one of
the four high abundant groups of A, B, E, or D.

To give a real-life biological example, Ishibama, et. al5 profiled the protein abundance of
Escherichia coli (E. coli) cytosol. They found that the most abundant proteins were involved in
protein synthesis, energy metabolism, and binding functions. Those proteins in low abundance
were mainly involved with metabolism, transcription, transport, and cellular organization. 5

The abundance and concentration of these proteins are vital information for scientists especially
because they can often indicate some sort of biological activity (e.g., presence of a disease or
infection). Biomarkers can be defined as clinical, molecular, or image-based measures of a
patients’ biological state.3 It can be a biological molecule that is found in the blood, serum, or
other bodily fluids as well as in tissues that indicates any sign of a normal or abnormal process,
or even a condition/disease.6 Biomarkers are useful in clinical settings when they can be
accurately measured quickly and repeatedly, provide unique information about a patient, and
assist in any decision making involving the diagnosis and prognosis. For example, biomarkers
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could be used to determine if a patient has a disease or to understand a patient’s response to a
drug or a therapeutic treatment. Additionally, biomarkers are especially helpful when they can
provide information that can lead to a more personalized clinical approach, meaning that doctors
can provide more uniquely designed care plans for their patients. This could involve knowing
what stage of cancer the patient is at and how their cancer may progress, how long an infection
might last, the specific dosage of a drug that would be required, etc.3 A biomarker could fall into
the class of low abundance proteins. Therefore, an inability to detect the low abundant proteins
indicates an inability to detect a disease or the onset of a disease, the efficacy of a drug for a
disease, any side effects of a drug or therapy, etc. which could be costly. For example, referring
back to albumin, its normal concentration in healthy adults is around 3.5 to 5 g/dL and in healthy
children around 2.9 to 5.5 g/dL.7 If, for example a drug candidate was introduced after the onset
of a disease or infection, any shift in the abundance or concentration of this protein
category/type in a proteome could indicate the drug’s efficacy/inefficacy or any side effects that
occur.

1.2 Current Techniques for Proteomic Analysis
The gold standard of protein analysis for many years has been electrophoretic-based methods.
These methods separate proteins based on their overall charge and are compared to a molecular
weight standard.2 Gel electrophoresis is commonly used for comparing two similar samples in
order to find differences in protein composition between the two. ELISA has been commonly
used for protein analysis notably because of its extreme sensitivity. It is capable of quantifying
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proteins in the low pg/mL range which is approximately 1 million-fold lower than the limits in
other proteomic methods (e.g., nontargeted approaches).8

Molecular mass spectrometry is also commonly used for protein analysis most notably due to its
selectivity (the quality of response to a substance without interference by another).2,8 Among
these is matrix-assisted laser desorption ionization – time of flight mass spectrometry (MALDITOF MS) which is most commonly used as a means of characterizing large biomolecules in
particular. This method can detect more than 2500 proteins simultaneously.9 Relative
quantitation can be achieved using molecular mass spectrometry based on a variety of strategies
that are based on isotope-coded labeling.2

Despite the strength of these methods, there are some major drawbacks when it comes to the
detection and quantitation of low abundance proteins. These are enumerated in the following
section.

1.3 The Challenges in Proteomics
While electrophoretic-based methods are capable of detection proteins at a very low level, they
lack the specificity, throughput, and speed for clinical applications. One of the main limitations is
the lack of specificity, or the ability to detect the target analyte in the presence of other
components.9 This is a major drawback for the measurement of low abundance proteins given
that high abundance proteins often mask their presence. Additionally, these techniques often
only facilitate simplex analysis, meaning that they can only really detect one target analyte at a
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time. Some novel labels have been developed that allow for multiplex analysis (analysis of
multiple target analytes), however, often emission lines overlap making it difficult to distinguish
between the two.4 Lastly, method development for a sandwich enzyme-linked immunosorbent
assay (ELISA) can often take more than a year to generate, screen, and prepare antibodies for the
particular target of interest.8,9 Due to these limitations, this approach is not ideal for the analysis
and quantitation of biomarkers.

Molecular mass spectrometry, in gaining the advantage of specificity, loses the sensitivity of the
electrophoretic-based methods.8 However, the sensitivity is crucial for the analysis and
quantitation of low abundance proteins which are vital in biomarker discovery.

Additionally, molecular mass spectrometric methods often lack the ability to perform absolute
quantitation. Absolute quantitation refers to the determination of the amount of a substance of
the analyte in a sample. It can be compared to relative quantitation, which is what many
molecular mass spectrometers can perform. Relative quantitation is the determination of the
amount of an analyte in a sample in relation to the amount of another reference sample.10 For
biomarker discovery, absolute quantitation is ideal to better detect changes in the quantity of
protein in a sample/organism. Molecular mass spectrometric methods currently utilize soft
ionization sources that preserve structural information which allows for protein identification.
However, this causes issues for quantitation because the provided signal intensity does not
directly relate to the analyte amount due to the mass spectrometer’s structure dependent
response (which is based on size, hydrophobicity, matrix, solvents used, etc.). 10,11 Current
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methods for mass spectrometry, in order to provide a protein quantity, covalently bind isotope
labels to proteins. In this method, when hyphenated to a chromatographic instrument (e.g.,
HPLC), the sample is labeled with a light and heavy isotope which both coelute due to their
otherwise identical properties. This reveals a mass shift that relates to the number of heavy
isotopes placed on the sample. To quantitate, the intensity ratio between the heavy and light
peaks to each protein would be measured. The ratio, however, only provides a relative quantity,
since it is determining the quantity of the analyte relative to another compound that was
measured.10 Despite this value still being valuable in certain applications, it is a hope to find
absolute quantities for more accurate and personalized medicinal treatment plans.

Both of the commonly used methods for proteomic analysis have limited clinical utility. It is
estimated that no more than 30% of the expressed proteins are detectable using these standard
analytical methods.1 Therefore, it is important to find a method/technique that is sensitive,
specific, has high throughput, and is capable of absolute quantitation so that biomarkers, and
other various proteins in the body, can be analyzed and quantitated regardless of their
concentration.

1.4 Why does this matter?
In order to expand and develop the knowledge and information about proteins, methodologies
that are not limited by low sensitivity and simplex analysis capabilities are necessary.12 Being able
to measure the quantity of proteins or how much this quantity changes provides information that
is important to detect changes in a biological system and to better understand how proteins
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function and interact when responding to different stressors.10, 11 For example, being able to
quantify these changes can help us to detect cellular responses to drugs, environmental stresses,
the progression of a disease, etc.12 Applying this to future clinical and diagnostic applications, the
measure or change in protein quantity can reveal changes in a biological system that could detect
biomarkers that are present in low abundance. If these biomarkers are detected, it could lead to
early disease diagnosis and prognosis of new diseases, and also allow for treatments to be
developed earlier.4,
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Additionally, absolute quantitation of the proteins that make up the

biomarker can provide more accurate and uniquely personalized treatments and dosage plans
for patients. As stated earlier, some important biomarkers tend to exist more in a region of low
abundance proteins that span over a wide dynamic range.4 Therefore, a lack of methods to more
precisely measure changes of proteins in low abundance, despite their biological importance, has
hindered the ability to discover more biomarkers and the knowledge and understanding of more
protein responses to stimuli changes.12 Thus, the importance in finding the method that has a
wide dynamic range, enhanced sensitivity, and multiplex analysis will allow for the detection of
these biologically significant proteins to improve and develop better diagnostic biomarker
panels.12

1.5 Proposed Solution – Thesis Statement
This project seeks to lay the groundwork for the use of a single quadrupole ICP-MS method to
perform absolute quantitative proteomic analysis using lanthanide labeled, DOTA-conjugated
proteins.
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The ICP-MS must be adapted to analyze low abundance proteins, however, in order to analyze
low abundance proteins, they must be derivatized to make them amenable for elemental mass
spectrometry measurement. The derivatization scheme can be seen in Figure 2. The first step
involves the conjugation of DOTA (a chelator) to BSA (the protein). The second step is where the
DOTA “traps” the lanthanides, labeling the protein with the metal.

Figure 2. Protein derivatization scheme to make protein amenable to ICP-MS analysis. Panel A represents the
theoretical expectation of how the DOTA will conjugate and how the lanthanide will be labeled to the protein.
Panel B represents the structural information of the scheme, showing DOTA, the chelator, and how the BSA
attaches, along with how the lanthanide coordinates with the DOTA.

After being measured via ICP-MS the concentration of the lanthanide will then be mathematically
converted to the concentration for the protein seen in Equation 1.
𝑚𝑜𝑙 𝐿𝑛3+
𝑚𝑜𝑙 𝐷𝑂𝑇𝐴
𝑚𝑜𝑙 𝐿𝑛3+
×
=
𝑚𝑜𝑙 𝐷𝑂𝑇𝐴 𝑚𝑜𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑚𝑜𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
Equation 1. Stoichiometric determination of the biomarker concentration based on the concentration of the
lanthanide.
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Most methods taking advantage of the ICP-MS analytical figures of merit have utilized an
instrument with a triple-quadrupole mass analyzer. The triple-quadrupole (Q-q-Q) mass analyzer
has greater sensitivity and wider dynamic range compared to a single quadrupole mass analyzer.
This project, however, wants to evaluate a single quadrupole mass analyzer to allow for greater
accessibility and cost effectiveness. It hopes to establish and validate a less sensitive mass
analyzer for the conjugation reaction of DOTA (a chelator) to the protein in terms of time,
temperature, and pH in order to have the ideal reaction conditions that provide the most
accuracy and precision. This will set the foundation for future projects involving the loading of
the lanthanide metal onto the DOTA-conjugated protein as well as the reaction meant to
“capture” the biomarker that allows for analysis and quantitation of the biomarker.

This paper will not only review past papers and conduct a literature review but will also provide
preliminary data and experimental results from the ICP-MS analysis and DOTA-conjugation
reactions.
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Chapter 2 – Analysis of Lanthanides in Straight Solution via ICP-MS
2.0 Introduction
In Chapter 1, it was mentioned that the instrument of choice was the inductively coupled plasma
mass spectrometer (ICP-MS) which is an elemental/atomic mass spectrometer. In this chapter, it
is important to justify and validate the use of the ICP-MS for the stated purpose.

Currently, molecular mass spectrometric systems with various mass analyzers are used for
proteomics studies. MALDI-TOF (matrix-assisted laser desorption ionization – time of flight) mass
spectrometry was mentioned as an example in Chapter 1. Other systems are presented in Table
2 and show that the dynamic range of molecular mass spectrometric systems range from
1.0 × 103 𝑡𝑜 1.0 × 106 with most of them lying on the lower end of the range.
Table 2. Selected performance characteristics of mass spectrometers that are typically used for proteomic
studies. Adapted from Yates et.al.13

Instrument
QIT
LTQ

Mass resolution
1000
2000

Sensitivitya
Picomole
Femtomole

Dynamic range
1 x 103
1 x 104

Q-q-Q

1000

Attomole to femtomole

6 x 106

Q-q-LIT
TOF
TOF-TOF
Q-q-TOF
FTICR
LTQ-Orbitrap

2000
10000 - 20000
10000 - 20000
10000 - 20000
50000 - 750000
30000 - 100000

Femtomole
Femtomole
Femtomole
Femtomole
Femtomole
Femtomole

4 x 106
1 x 104
1 x 104
1 x 104
1 x 103
4 x 103

a Although

this is labelled sensitivity, it seems to us that the authors implied instrument detection limit since
unit of sensitivity is signal per concentration or quantity of analyte.

As noted in Chapter 1, molecular mass spectrometric systems with various mass analyzers are
currently the workhorse for proteomics studies.14 Mass analyzers which are commonly used
along with these systems are presented along with their corresponding performance
16

characteristics. The Fourier transform ion traps (FTICR and Orbitraps) have the highest mass
resolution and better sensitivities compared to the quadrupoles. However, with regards to the
dynamic ranges, the quadrupoles are much better. Additionally, quadrupole systems are more
accessible due to a cheaper cost.

Regarding their applicability to proteomic studies, the dynamic range of proteins in proteomes
should be considered. From Figure 3, it can be observed that the dynamic concentration range
of proteins in a typical proteome span over twelve orders of magnitude. This is six orders of
magnitude beyond the dynamic range capability of molecular mass spectrometric systems (when
comparing information on both Table 2 and Figure 2).

Figure 3. Plot of the dynamic concentration range of plasma proteins, spanning 11 orders of magnitude. Yellow:
clinically used biomarkers; red: proteins discovered by the HUPO Plasma Protein Project. 1
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Therefore, these current proteomic methods fall short of the dynamic range requirements
capable of covering the concentration dynamic range of proteins in a typical proteome.

Low abundance proteins are often found in the pg/mL concentration range in the same matrix as
high abundance proteins (HAPs) that are present in the mg/mL concentration range (seen in
Figure 3). Therefore, low abundance proteins (LAPs) are often masked by the HAPs and left
undetectable using current methods. Unfortunately, some of the LAPs could potentially be
biomarkers of interest.

To address this problem, some authors have employed sample preparation that involve protein
depletion (HAPs) and enrichment (LAPs) strategies. Some of these methods are presented in
Figure 4. There are non-affinity-based methods, such as the use of membrane filtration
concentrators,

dialysis,

precipitation/dry-down/salting

out,

and

molecular

sieving

chromatography. These are used to concentrate the protein solute by removing the fluid solvent
along with smaller molecules.2 However, these methods all have significant drawbacks including
length of time, disruption of the function of proteins, lack of sensitivity, and multiple
requirements necessary to complete the pre-analysis sample preparation.
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Figure 4. Strategies for removal of high abundance proteins. 15

There are also affinity methods that include affinity immunodepletion (the removal of unwanted
high abundant proteins) and affinity capture and enrichment (which enhances the biomarker/low
abundance protein of interest).2

Immunodepletion is often used as a sample preparation method for molecular mass
spectrometry-based analyses. However, immunodepletion has many drawbacks that make it
insufficient. One such limitation is that the low abundance proteins that are being analyzed may
form a complex with those high abundance proteins that are being depleted. If this complex is
formed, the low abundance proteins are depleted along with it and removed from the sample.
Secondly, using an affinity immunodepletion column often carries the risk of carry-over from
previous samples that had been run ultimately causing contamination.2
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Other affinity capture methods have been found to be useful for mass spectrometric methods.
These include binding the protein of interest to molecules such as antibodies, aptamers, etc. that
are known to have a specific target to bind to. These are very useful in successfully and efficiently
binding to their target protein allowing the proteins of interest to be concentrated for better
detection and analysis. However, due to their specificity, they are limited to known targets.
Therefore, the use of this affinity capture methods hinders the discovery of new biomarkers that
are unknown. Another affinity capture methods uses a molecule that can bind to a variety of
different proteins; it is less specific and does not target a specific protein. This could include a
dye or a metal, etc. However, this method requires advanced planning along with necessary
genetic modification or chemical labeling of unknown proteins prior to analysis which could be
time consuming and laborious.2

In conclusion, although these methods have their advantages, they still run the risk of not being
able to deplete all of the high abundance proteins, accidentally removing important low
abundance proteins, inability to discover new biomarkers, and a more time-consuming sample
preparation.

2.0.1 Elemental (Atomic) Mass Spectrometry
On the other hand, elemental mass spectrometry, particularly the ICP-MS, is capable of
performing with a dynamic range of up to twelve orders of magnitude, especially when analyzing
transition metals (e.g., lanthanides). This provides an opportunity to use elemental mass
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spectrometry for the analysis of proteins, with appropriate preparation to make the sample
amenable to it. Therefore, this project proposes the use of a single quadrupole ICP-MS for the
measurement of proteins. In the future, the method being developed will hopefully be applied
to low abundance, low concentrated proteins in biological samples.

Besides the wide dynamic range, the ICP-MS has the ability to measure multiple elements and
their isotopes simultaneously with high sensitivity and accuracy. Additionally, due to its high
temperature (6000-8000 K) it destroys matrices completely and makes measurement
independent of the analyte matrices. The high temperature also facilitates efficient ionization of
elements thereby leading to a limit of detection in the sub ng/L (ppt) range. ICP-MS interfaces
with separation techniques (particularly chromatography and capillary electrophoresis) very
easily. This can be used to purify the sample prior to analysis. 10,11,12,16

The initial focus is to determine what the analytical performance of the single quadrupole ICPMS for the detection of the metals is in 2% nitric acid (the common solvent used for preparing
samples to be detected in the standard mode). The next question is what is the performance of
the same system in an organic acid environment (e.g., acetate buffer – this is the solvent that
would be used in transient mode)? These two questions are important because the first
generates baseline information to which the second is compared. The second question is
necessary because the configuration of the ICP-MS in this mode allows for the utilization of
microliter volumes of sample which is representative of the volume of samples typically available
from biological systems.
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The two solvents will be compared via five analytical figures of merit: sensitivity, detection limit,
quantitation limit, background equivalent concentration, and R2 value (linearity) to evaluate the
performance. However, among these figures, background equivalent concentration will be used
as the priority parameter to decide in which solvent the ICP-MS performance is optimal since the
BEC relates to the practical limit of quantitation.

2.1 Experimental – Standard Mode
2.1.1 Protocol
Four lanthanides from Strem Chemicals were investigated in this experiment using their salt
forms: praseodymium (III) chloride, anhydrous (CAS 10361-79-2); neodymium (III) chloride,
anhydrous (CAS 10024-93-8); gadolinium (III) chloride, anhydrous (CAS 10138-52-0); and
samarium (III) chloride, anhydrous (CAS 10361-82-7).

2.1.1a Calibration and Sample Preparation in 2% Nitric Acid (v/v)
A primary stock solution for each individual lanthanide was prepared by dissolving about 0.1
grams of the salt in 2% nitric acid (v/v). A 100-ppm primary intermediate solution followed by a
1-ppm secondary intermediate solution was prepared for each individual lanthanide. Finally, a 1ppb secondary stock solution was prepared containing all four lanthanides. All solutions were
prepared using 2% nitric acid (v/v).
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Calibration standards were prepared in three different range: 0.01 – 0.1 ppb, 0.1 – 1.0 ppb, and
1.0 – 10 ppb. All standards were prepared using 2% nitric acid (v/v). The samples used in this
protocol consisted of the calibration standard concentrations but analyzed as samples.

2.1.1b Calibration and Sample Preparation in 0.1 M Acetic Acid Buffer at pH 4.8
The acetic acid buffer was prepared using ammonium acetate (Sigma Aldrich CAS 631-61-8) and
concentrated acetic acid (17.4 M) with a concentration of 0.050 M each. A primary stock solution
for each individual lanthanide was prepared by dissolving about 0.1 grams of the salt in the 0.1
M acetic acid buffer (~pH 4.77). A 100-ppm primary intermediate solution followed by a 1-ppm
secondary intermediate solution was prepared for each individual lanthanide. Finally, a 1-ppb
secondary stock solution was prepared containing all four lanthanides. All solutions were
prepared using the 0.1 M acetic acid buffer (~pH 4.77).

Calibration standards were prepared in three different ranges: 0.01 – 0.1 ppb, 0.1 – 1.0 ppb, and
1.0 – 10.0 ppb. All standards were prepared using the 0.1 M acetic acid buffer at pH 4.77. the
samples used in this protocol consisted of the calibration standard concentrations ran as samples.

2.1.2 Instrumentation
The ICP-MS was operated under the following conditions seen in Table 3.
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Table 3. Instrumental parameters for the ICP-MS in Standard Instrument Mode and the three different gas
modes.

Plasma Parameters
RF power
RF Matching
Sampling Depth
Carrier Gas
Option Gas
Nebulizer pump
Oxide Ratio (156/140)
Ratio (2+) (70/140)
Lenses Parameters
Extract 1
Extract 2
Omega Bias
Omega Lens
Cell Entrance
Cell Exit
Deflect
Plate bias
Cell Parameters
Oct Bias
Oct RF
Energy discrimination

No Gas Mode

Helium Mode

High Efficiency
Helium Mode
(HEHe)

1550 W
1.80 V
8.0 mm
1.03 L/min
0.0%
0.10 rps
1.105%
1.079%

1550 W
1.80 V
8.0 mm
1.03 L/min
0.0%
0.10 rps
1.526%
1.355%

1550 W
1.80 V
8.0 mm
1.03 L/min
0.0%
0.10 rps
1.443%
1.848%

0.0 V
-195.0 V
-100 V
10.4 V
-30 V
-50 V
12.8 V
-40 V

0.0 V
-195.0 V
-100 V
10.4 V
-40 V
-60 V
10.0 V
-55 V

0.0 V
-195.0 V
-100 V
10.4 V
-150 V
-150 V
-65.0 V
-150 V

-8.0 V
170 V
5.0 V

-18.0 V
170 V
3.0 V

-100.0 V
200 V
7.0 V

2.2 Results
After all calibration standards and samples were analyzed on the ICP-MS, the data was collected
and put into tables. Each standard and sample were analyzed in three different modes: no gas
mode, Helium mode (He), and high efficiency helium mode (HEHe).

The analytical figures of merit mentioned in these results include the limit of detection/detection
limit (LOD), the limit of quantitation/ quantitation limit (LOQ), sensitivity, background equivalent
concentration, and R2 value (linearity). Most of these values, excluding the quantitation limit,
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were outputted by the instrument. The sensitivity of the instrument was determined from the
slope of the calibration curve. The background equivalent concentration is the signal at a
concentration of zero converted to the concentration unit using the corresponding relevant
calibration equation. The R2 value is the percentage of data explained by the trend line. The
detection limit is equivalent to three times the standard deviation divided by the slope of the
calibration line ( 𝐿𝑂𝐷 =

3𝑠
𝑚

). The quantitation limit was back calculated from the detection limit

and the sensitivity (the slope of the calibration line, m) since the quantitation limit is ten times
the standard deviation divided by the slope of the calibration line ( 𝐿𝑂𝑄 =

10𝑠
𝑚

).18 The sensitivity

is important to be able to measure the analyte that has a low concentration with a high signal
intensity. The detection and quantitation limits are important to be able to reliably detect and
measure the amount of analyte present, especially when low in low levels.

Since there were three gas modes for each element, and two different solvents were analyzed,
six tables for each element were made to compare the analytical figures of merit of each mode
and calibration range in the two different solvents. The raw results from these can be seen in
Appendix A.

The tables below (Tables 4-8) represent a summary of the analytical figures of merit for each
element in both 2% nitric acid (v/v) and the acetic acid buffer (pH 4.77). There are two important
items to note: (1) The four elements were analyzed from 0.01 to 10 ppb, but the tables highlight
the lowest range (0.01 to 0.1 ppb) representative of the concentration seen in a biological system,
and (2) the tables highlight the analytical figures of merit analyzed in their respective ideal gas
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mode. The lowest background equivalent concentration (BEC) was used as a deciding parameter
to determine which mode (and solvent) was the optimal for analysis as it represents a more
practical limit of quantitation.
Table 4. Detection limits of each element in both solvents (refers to the lowest conc. of the analyte that can be
reliably detected)

Detection Limit (LOD, ppt)
Praseodymium

Neodymium

Samarium

Gadolinium

Nitric Acid

0.67

0.49

1.42

0.91

Acetic Acid

12.79

12.05

3.70

5.70

Table 5. Quantitation limits of each element in both solvents (o the lowest conc. of analyte that can be reliably
measured)

Quantitation Limit (LOQ, ppt)
Praseodymium

Neodymium

Samarium

Gadolinium

Nitric Acid

2.24

1.63

4.73

3.04

Acetic Acid

42.63

40.16

12.33

18.99

Table 6. Background equivalent concentrations (BEC) of each element in both solvents (refers to the practical
limit of quantitation)

Background Equivalent Concentration (BEC, ppt)
Praseodymium

Neodymium

Samarium

Gadolinium

Nitric Acid

0.46

0.78

0.94

0.56

Acetic Acid

369.10

108.05

40.20

120.27
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Table 7. Linearity (R2 value) of each element in both solvents (maximum deviation from the calibration line)

Linearity (R2)
Praseodymium

Neodymium

Samarium

Gadolinium

Nitric Acid

0.9996

0.9683

0.9999

0.9669

Acetic Acid

0.9896

0.9829

0.9837

0.9615

The final analytical figure of merit, the sensitivity, was determined based on the limit of
detection. Referring back to Table 2, which stated the selected performance characteristics for
various molecular mass spectrometric systems, the sensitivities of many of the instruments were
only in the femtomole range, with the triple quadrupole system as the most sensitive system (in
the attomole range). Since these sensitivities were assumed to be calculated from the limit of
detection, to compare, the limit of detection of each element was converted to mol of protein
per deciliter as a way to report the sensitivity similarly to the author (seen in Equation 2).
1 𝑚𝑜𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
12 𝑚𝑜𝑙 𝐿𝑛

×

0.488𝑓𝑔 𝐿𝑛
𝑚𝐿

1𝑔

× 1015𝑓𝑔 ×

1𝑚𝑜𝑙 𝐿𝑛(𝑁𝑑)
144.24𝑔

×

103𝑚𝐿
10 𝑑𝐿

= 2.82 × 10−17

𝑚𝑜𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
𝑑𝐿

= 28.8

𝑎𝑡𝑡𝑜𝑚𝑜𝑙𝑒
𝑑𝐿

Equation 1. Calculation of the sensitivity of neodymium when prepared in 2% nitric acid (v/v) as compared to
Table 2. Note: 0.488 fg/ mL = 0.488 ppt (LOD); 12 mol Ln assumed mol of Ln loaded per protein based on 1:1
Ln: DOTA loading and assuming 12:1 DOTA: BSA conjugation; dL is used because this is the common unit of
volume used in this domain.

The calculated approximate sensitivities of each of the elements in their respective solvents are
shown in Table 8. Each of these values were calculated using Equation 2 and the lowest detection
limit of each element was taken.
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Table 8. Approximate sensitivities of each of the elements in both solvents (minimal detectable concentration)

Sensitivity (attomole/dL)
Praseodymium

Neodymium

Samarium

Gadolinium

Nitric Acid

39.7

28.2

78.6

48.4

Acetic Acid

756.3

696.0

205.1

302.0

2.3 Discussion
It can be seen in the tables above that 2% nitric acid consistently resulted in better analytical
figures of merit; the nitric acid solvent had lower detection and quantitation limits, lower
background equivalent concentrations, and better linearity. It was also found that the best gas
mode for analysis varied slightly among elements (this can be seen more graphically in the tables
presented in Appendix A). In summary, high efficiency helium mode had the highest analytical
figures of merit in both solvents among all elements making it consistently insufficient for
analysis. Helium mode and no gas mode varied in the lowest analytical figures of merit with
helium mode being the ideal mode for analysis when using the acetic acid buffer.

The acetic acid buffer was chosen with knowledge that the use of an organic solvent as the matrix
for lanthanides may enhance the signal and therefore improve sensitivity. It can be seen in the
results that this was not the case; additionally, other analytical figures of merit were affected
based on the choice of solvent. The detection limits and the quantitation limits of the elements
in acetic acid buffer were much larger than those in nitric acid (by a factor of ten). It is unknown
at this time why there is a loss of sensitivity using the acetic acid. This could be because the noise
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could also be enhanced when using the organic acid solvent producing higher detection and
quantitation limits. The noise may have increased due to the variation of aerosol particle droplet
sizes which may lead to the variation of analyte introduction into the plasma – the amount of
analyte reaching the detector at each instant varies more often. It is worth mentioning, however,
that the values of the detection and quantitation limits are still in the parts per trillion which is
notable for the proposed analysis.

It would be recommended for future analysis to consider other acidic buffers, such as a formic
acid buffer (with a pH around 3.75) to be used as a solvent. This may have the benefits of an
organic solvent and able to be used in the liquid chromatographer column, while also being more
acidic which could aid in the sensitivity and lower detection/quantitation limits seen with the
nitric acid.

Referring back to Table 2, one of the major investigations was to compare the sensitivity of a
single quadrupole mass analyzer system to other mass analyzers currently used in proteomic
analysis. As seen in Table 8, the sensitivity of the ICP-MS for the lanthanides prepared in 2% nitric
acid (v/v) is in the attomole range, making the use of this instrument comparable to the triple
quadrupole mass analyzer (Q-q-Q) and 1000 times more sensitive than all other systems. These
values indicate the concentration of protein that can be quantified based on the measurement
of the metal. This is to simulate possible numbers to compare to protein concentrations in cells.
The sensitivity when prepared in the acetic acid buffer is not as low displaying that the nitric acid
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can detect and quantify lower concentrations. Despite this, it is still worth noting that the acetic
acid buffer still provides good sensitivity comparably to the other instrument systems.

2.4 Conclusion
This experiment provides validation that the ICP-MS is a suitable instrument for the analysis of
lanthanides in acidic aqueous solutions. The detection and quantitation limits for both nitric acid
and an acetic acid buffer (pH 4.77) were in the ppt range. Similar to what has been previously
observed on other elemental mass spectrometric systems and better in quantifying lanthanides
than molecular mass spectrometry is able to quantify proteins, the use of a single quadrupole
mass analyzer for the determination of proteins via lanthanides is promising. In nitric acid, the
instrument displayed higher sensitivities and lower detection and quantitation limits compared
to the acetic acid buffer. Therefore, it would be important to continue exploring other acidic
solvents, perhaps other organic solvents, to determine an appropriate solvent that provides high
sensitivity comparable to nitric acid but is also suitable for liquid chromatography (in particular,
the column).
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Chapter 3 – Evaluation of NHS Chemistry for DOTA Conjugation to Bovine
Serum Albumin (BSA)
3.0 Introduction
Various labeling and tagging methods have been developed in order to quantitate proteins using
elemental mass spectrometry, for example, metal-assisted protein quantitation (MAPq) and
metal-coded affinity tags (MeCAT), etc.11 It is important to distinguish between a “label”
compared to a “tag” in terms of proteomic analysis. A label typically refers to a heteroatom that
is chemically attached to a biomolecule for quantitation, for example, a macrocycle (e.g., DOTA)
that has the ability to house the heteroatom, can be conjugated to the biomolecule. A tag refers
to a naturally present heteroatom that can be detected by the ICP-MS such as sulfur, phosphorus,
or selenium that are commonly found in many biomolecules.17

Labelling techniques are very useful to achieve higher selectivity and sensitivity for absolute
quantitative analysis of proteins using the ICP-MS. Utilizing labels, rather than tags, absolute
protein quantitation using the ICP-MS proceeds by directly measuring the proteins via the
heteroatoms attached. Although labeling techniques are often laborious and time-consuming,
they provide numerous advantages. For example, using labels allows for more than one element
to be placed on a protein that can be detected more easily than those elements already present
in the compound. Labeling the protein also allows for any protein peptide/protein to be
detectable by ICP-MS even if the protein/peptide does not already contain heteroatoms.10,11
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Previous focus has been on quantifying metals already present in proteins (especially
metalloproteins). For example, Fruncillo and coworkers19 developed an EDXRF (energy dispersive
X-ray fluorescence spectroscopy) based method for quantifying copper in proteins. In this, and
other similar approaches, metal/protein stoichiometry has been measured by other techniques.
However, in this work, the focus is to quantify proteins based on metals labeled to the protein.
To accomplish this task, it is necessary to know with certainty the metal/protein stoichiometry.

Due to this, deliberately labeling the protein with the metal complexing agent is important for
establishing metal protein stoichiometry. In most cases, the chosen label is an element with low
ionization and not found naturally. Due to this, the most used labels are the rare-earth elements
(lanthanides). Lanthanides not only have a low first ionization potential, but they also have low
background (since they do not naturally occur in biological samples).9,10,12 Therefore, they do not
obstruct the protein analysis allowing for easier determination and quantitation. Additionally,
the utilization of lanthanides allows for multiplex analysis capabilities because there are many
lanthanides available, along with their corresponding isotopes, that can be detected
simultaneously, and each be associated with a unique biomolecule. This is made possible by the
similar chemical properties of each lanthanide element to develop a multiplexed assay using ICPMS.9,10,12 These metals can be introduced to proteins via coordinate complexes.

The approach thus adopted involves the conjugation of a metal chelator to the protein and then
complexing a metal to the chelator. Measurement of the metal can then be used to determine
the concentration of the protein through the metal/protein stoichiometry.
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A requirement for an appropriate chelator is that the metal-chelator complex should be very
stable. Macrocyclic chelators are known to form very stable complexes. An example of this is
DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). Examples of the chelators
commonly employed are shown in Figure 5.

Figure 5. Frequently used macrocyclic chelator groups for the labeling of proteins. DTPA: Diethylenetriamine
pentaacetate; DOTA: 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid.

DOTA was chosen due to its thermodynamic stability when chelating to lanthanides. Table 9
shows the stability constants of lanthanide complexes to DOTA. The stability constant shows that
when the lanthanide is added to the DOTA, the complex formation will be favorable, and it will
remain stable. Since the quantitation of the protein relies on the lanthanide labeling the complex,
a high stability constant is useful to make sure that the lanthanide stays on the complex
throughout analysis.
Table 9. Stability constants of complexes with DOTA under various pH conditions and salt concentrations.20
Note: Promethium has no stability constant listed because it was not tested due to its radioactivity.
Lanthanide

La

Ce

Pr

Nd

Pm

Sm

Eu

Gd

Tb

Dy

Ho

Er

Tm

Yb

Lu

Log K
(DOTA)

22.86

23.39

23.01

22.99

-

23.04

23.45

24.67

24.22

24.79

24.54

24.43

24.41
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25.41

Furthermore, the chemical reaction that is used to conjugate the chelator to the protein should
satisfy the following criteria: (1) result in the formation of a stable bond between the chelator
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and the protein, (2) the reaction must be completed (close to 100%), (3) the reaction must be
specific (only reacts with the targeted functional group with limited side reactions), (4) the
reaction must be reproducible, (5) and it should not interfere with future/further analytical steps.
The hope for a complete reaction is not always necessary as long as there is constant
reproducibility and vice versa, otherwise no accurate correlation would be reported between the
measured signal and the concentration. 20 These reaction conditions can be seen in Table 10.
Table 10. Summary of the various labeling chemistries20,21

Reagent
Isothiocyanate

Target Group
-NH2

pH

N-hydroxy succinimide
(NHS) ester

-NH2

7.2-8.5

Imidoester
Carbodiimide
Maleimide
Haloacetyls

-NH2
-COOH
-SH
-SH

8.0 – 10.0
4.5 (acidic)
6.5 – 7.5
7.2 – 9.0

Pyridyl disulfide

-SH

4.0 – 5.0

Hydrazide
Alkoxyamines
Aryl azides
Diazines

-CHO
-CHO
Non-selective
Non-selective

5.0 – 7.0

As seen in Table 10, the most common functional groups that are targeted include primary
amines, sulfhydryls, carbonyls, carbohydrates, and carboxylic acids. A few examples of these
functional groups can be seen on the residues seen in Figure 6. There are some non-selective
functional groups, such as photo-reactive groups that can be used as well.21
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Cysteine

Lysine

Asparagine

Figure 6. Common residues targeted for bioconjugation.

In this proposed scheme, the DOTA molecule is first conjugated to the protein to be measured.
The metal (a lanthanide in this case) is then complexed to the DOTA moiety. DOTA can be
crosslinked to proteins through a variety of chemistries seen in Figure 7.

Figure 7. Examples of DOTA labeling chemistries for the derivatization of proteins. R represents DOTA or a
group containing DOTA20
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Amine-reactive chemical groups (e.g., isothiocyanate and NHS ester) are commonly used since
many of the primary amines (𝛼-amine at the N-terminus and 𝜀-amine on the side chain of lysine
residues) are on the outer surface of the protein due to the positive charge at normal biological
conditions (pH 7). Since the primary amines are outward facing, they are more accessible for
conjugation without denaturing the protein. 21,22

Carboxylic-reactive chemical groups (e.g., carbodiimides) are also commonly used since many
carboxylic acids (-COOH on asparagine and glutamine residue side chains) are present on the
surface of the protein structure since they have a negative charge at normal biological conditions.
However, these groups are also capable of causing conjugation to primary amines as well causing
more of a random conjugation process. Additionally, often NHS esters are used tandem to the
carbodiimides to improve efficiency.21

Sulfhydryl-reactive chemical groups (e.g., maleimides, halo acetyls) target the -SH groups on the
side chains of cysteine residues. When part of a secondary or tertiary structure, many cysteine
residues form a disulfide bond (-S-S-). In order crosslinking and conjugation to occur, these
disulfide bonds must be reduced to their -SH groups for many reactive groups.21

Carbonyl-reactive chemical groups (e.g., hydrazides) are not used as often. This linking chemistry
is specifically useful for glycoproteins that contain reducing sugar moieties.
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The last group of various labeling chemistries are the photo-reactive crosslinkers, often used for
nonspecific conjugation (e.g., aryl azides and diazines). These reagents are mainly used as
heterobifunctional crosslinkers; they can capture binding partner interactions. These reagents
are activated/become reactive when exposed to ultraviolet or visible light.21

The type of labeling reaction this project utilizes is the NHS ester reagent chemistry due to its
high stability and efficiency compared to other crosslinking reagents. NHS esters, as seen in Table
10 react strongly with the primary amino groups in a protein (-NH2 groups which could be located
at the N-terminus or the side chain lysine for example).21,22 The reaction that occurs forms a
stable amide bond between the primary amine and the DOTA-NHS conjugate at pH 7.2-8.5 at 4°C
ranging from a time of 30 minutes to 4 hours.21 This reaction scheme can be seen in Figure 8.

Figure 8. NHS reaction scheme for chemical conjugation to a primary amine (-NH2). (R) represents a labeling
reagent DOTA that has the NHS ester reactive group; (P) represents the protein (BSA) that contains the target
functional group (i.e., primary amine)21

In this project, bovine serum albumin (BSA) will be used as a substitute for antibodies in order to
establish the method as well as optimize the reaction conditions, as well as due to the low cost
of BSA compared to antibodies. Given that BSA has 60 lysine groups on it, ideally, after the
labeling reaction occurs, 60 moieties of DOTA would be conjugated to the protein. When adding
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the lanthanide, then, ideally 60 mol of Ln would be complexed to the 60 moieties of DOTA
ultimately enhancing the signal and improving the sensitivity.

There are some limitations to this approach. Although the reaction is “specific” to -NH2 groups,
it is generally nonspecific since it will not only react with the reactive group on the lysine, but
also the N-terminus amine. This could affect how many moieties of the DOTA, and eventually,
the Ln will be on the protein which may change the signal that is seen from the ICP-MS after
analysis. The chance of this occurring can be limited by carrying out the reaction at a specific pH.
For example, at pH 7.0, the reaction favors the amine on the N-terminus. At a pH greater than
8.0, the reaction has a higher chance of reacting with the amino groups on the lysine side chain.15
Therefore, in order to enhance the favorability of reacting with the amine on the lysine amino
acid residues, a pH of ~8.4 may be most useful.

In this project, bovine serum albumin (BSA) was selected as a pilot protein to evaluate their
reliability and functionality of the DOTA conjugation reaction.

3.1 Experimental
3.1.1 Materials and Methods
3.1.1a Preparation of Samples for IM-TOF Analysis

A 0.5 M sodium bicarbonate (NaHCO3 - VWR Chemicals Lot # 20G1456066 MW 84.01) buffer at
a pH of 7.2 – 7.5 was prepared first and then diluted to a 50 mM NaHCO 3 buffer for sample
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preparation. A 5 mg/mL solution of DOTA-NHS ester (Macrocyclics LOT: B2801004-190619) was
prepared in dimethyl sulfoxide (DMSO – Fisher Scientific LOT # 702398). The bovine serum
albumin (BSA – Sigma Aldrich LOT # SLCG231; CAS 9048-46-8) was prepared initially as 10 mg/mL
in the NaHCO3 buffer and then diluted to 3.0 mg/mL in the same buffer for reaction preparation.

Six samples were prepared: (1) Freshly prepared BSA that does not undergo the reaction and
washing process, (2) freshly prepared BSA without the addition of DOTA that does undergo the
reaction process, (3) BSA prepared a week earlier without the addition of DOTA that undergoes
the reaction process, and (4,5,6) BSA with the addition of DOTA. The buffer, DOTA-NHS ester
solution, and BSA solution were then placed in the corresponding 10kDa Amicon filter tube,
covered in foil, placed in the fridge (4°C), and allowed to react for 60 minutes. The reaction
proceeds as seen in Figure 9.
O

O

OH

OH

O

O
N

500x molar
equivalence DOTA

N

N

N
OH

OH

+ BSA

OH
N

50 mM, pH 7.2
bicarbonate
buffer, 4°C dark,
60 minutes

N

O
O

OH

O

N

N

O
HN
O

O
N

BSA
O

Figure 9. Conjugation reaction of the DOTA-NHS ester with the bovine serum albumin to create the stable
amide bond between the DOTA chelator and the BSA forming the conjugated BSA.

A 1 M Trizma-HCl buffer (SIGMA T-3252 Lot # 37H5743; Tris[hydroxymethyl]aminomethane
hydrochloride; MW 157.6) at pH 7.2 was prepared and used to prepare a 20 mM Trizma-HCl
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buffer at the same pH. After the reaction was allowed to react for the intended reaction time (60
minutes), all solutions were “washed” using this Trizma-HCl buffer using a centrifuge to switch
from the carbonate buffer to the Trizma-HCl buffer, stopping the reaction. The solutions were
then reconstituted into the Tris buffer.

This set of samples was sent to Corteva to be analyzed via Ion-Mobility Time of Flight (IM-TOF)
mass spectrometry.

3.1.1b Preparation of Samples for SDS-PAGE Analysis
Samples were prepared as stated above under Preparation of Samples – Analyzed via IM-TOF.
Following the “washing” protocol, 1 mg/mL of the sample was placed in a tube along with 1x
PBS, and 4x LDS sample buffer (Invitrogen NuPAGE by ThermoFisher Scientific; Lot # 2303565).
All samples were incubated at 95°C for 5 minutes to complete the sample denaturing process
and then loaded into the wells of the gel (Novex WedgeWell 12% Tris-Glycine Gel; 1.0 mm x 10
mm well; ThermoFisher Scientific) as displayed in Figure 10.
1

2

3

4

5

6

MW Protein
Standard

BSA alone 11/3
Unprocessed

BSA Alone
10/29
unprocessed

BSA alone
10/29
processed

DOTA-BSA 1

DOTA-BSA 2

Figure 10. Order of samples loaded into the gel. The MW Protein Standard (SeeBlue Plus2 Prestained Standard
LOT 2281190) was loaded at a volume of 10 L while the samples were loaded at a volume of 7 L

A 1x running buffer was prepared from a 20x MES running buffer (NuPAGE; Novex LOT 236978)
to fill the gel tank. The SDS-PAGE was then run on the Invitrogen PowerEase Touch 120 W at a
voltage of 200 V for 30 minutes. After the run was finished, the gel was rinsed, and then stained
with the SimplyBlue SafeStain (LOT 2271092).
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3.1.2 Instrumentation
3.1.2a Conditions for Ion-Mobility Time of Flight Mass Spectrometry
Samples were stored at 4°C until they were analyzed. Protein samples were injected using 20%
Buffer B (Buffer A = 40 mM ammonium acetate pH 9.5, Buffer B = 95:5 Acetonitrile: Methanol) at
a flow rate of 400 L/ min on an Imtakt Itrada WP-RP (150 mm x 3 mm, 2 m) column. The
mixture was then separated with a linear ramp to 70% buffer B at 15 minutes, 95% Buffer B at 17
minutes, holding at that Buffer B percentage until 20 minutes before returning to 20% Buffer B
until 25 minutes and the run ended. Separated species were ionized using positive polarity
electrospray ionization onto an Agilent 6560 ion mobility spectrometer time of flight mass
spectrometer under the following source conditions seen in Table 11:
Table 3. Operating conditions for the ion mobility time of flight mass spectrometer (IM-TOF).

Gas Temp
Gas Flow
Nebulizer
Sheath Gas Temp
Sheath Gas Flow
VCap
Nozzle Voltage
Fragmentor
Skimmer
Octopole RF Peak

350°C
12 L/min
60 psig
400
11
5500
2000 V
380
1=30
750

The instrument acquired single injection drift time resolved mass spectra between m/z 500 and
3200. Following data acquisition, additional data analysis was complete using UniDec version
5.0.2.

3.2 Results and Discussion – Conjugation Analysis via IM-TOF
From the ion mobility time of flight mass spectrometer, the results are as follows:
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The freshly prepared BSA can be seen in the convoluted and deconvoluted spectra seen in Figure
11.

Convoluted
BSA Alone

Deconvoluted
BSA Alone

Figure 11. Convoluted (left) and deconvoluted (right) spectra for the freshly prepared BSA giving a molecular
weight of 66,430 kDa.

The mass spectrum above all tells us that the molecular weight of the BSA purchased was around
66,430 kDa. The vendor also reported this molecular weight meaning that this analysis is
accurate. This provided the preliminary data to give us the reference molecular weight of the BSA
that could be used to compare to the following results to see any shift in mass.
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Figure 12 compares the freshly prepared BSA that was unprocessed and freshly prepared BSA
that went through the reaction conditions without the addition of DOTA. This comparison was
done to determine if the BSA was stable under the reaction conditions.

Fresh BSA No Reaction,
No DOTA

Fresh BSA –
With Reaction,
No DOTA

Figure 12. Comparison of the freshly prepared BSA alone that did not undergo the reaction conditions (left)
and the BSA alone that did undergo the reaction conditions without the addition of DOTA (right). These are the
deconvoluted spectra.

It can be seen in these two spectra that there was no significant change in the state of BSA when
undergoing the reaction conditions (e.g., put in the fridge, washed in Tris buffer, etc.). The
molecular weight that appears on the mass spectrum that did undergo the reaction conditions
has a molecular weight very close to 66,430 Da (off by about 6 Da). There is a peak at 33,219 Da
which could be a fragment that broke off, or the sample that is doubly charged (BSA with a +2
charge instead of a +1 charge). Despite this, the majority of the sample remained intact and was
still usable in the experiment. Therefore, this study shows that BSA is not decomposed by the
reaction conditions.
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Figure 13 compares two samples of BSA prepared on different dates. This comparison was done
to determine if the BSA was stable after sitting in the fridge for four weeks; if the BSA was not
stable, potential degradation peaks may appear.

BSA – Week 1, No
DOTA

Fresh BSA – Week
4, No DOTA

Figure 13. Comparison of freshly prepared BSA alone (left) and BSA alone prepared four weeks earlier left to
sit in the fridge (right). Both of these samples underwent the reaction process without the addition of DOTA.
These are the deconvoluted spectra.

Again, there are no significant differences between the two spectra; both of the BSA samples that
were analyzed on different dates had very similar molecular weights (only off by 1 Da). This study
shows that the BSA can be stored for up to four weeks with no degradation or significant change
in its structure.

Figure 14 compares the BSA alone with the DOTA-conjugated BSA. This comparison was done to
determine if the DOTA was actually being conjugated to BSA.
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BSA Alone

DOTA-conjugated
BSA

Figure 13. Comparison of the freshly prepared BSA alone (left) to DOTA conjugated BSA (right). These are the
deconvoluted spectra.

Due to the significant change in the number of peaks present in the spectrum where DOTA was
added, shows that conjugation occurred. Additionally, the spectrum for BSA alone is much clearer
compared to the busy DOTA-BSA spectrum.

Each of the peaks in the DOTA-conjugated BSA spectrum has its own corresponding mass. The
peaks are labeled by colored shapes and their masses can be seen in Figure 14. The leftmost peak
in the DOTA-conjugated BSA spectra corresponds to the purple circle at 34,571 Da and increases
by mass as you move to the right.
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Figure 14. Corresponding masses to the DOTA-conjugated BSA spectra seen in Figure 13 on the right.

The masses that were of most interest was those above the mass of BSA alone; anything higher
than molecular weight of 66,430 Da was a possible BSA-DOTA conjugate species. These species
can be seen in Figure 15. Anything less than the molecular weight of 66,430 Da are most likely
fragments of the sample that broke off.

Figure 15. Possible DOTA-BSA conjugate species. Using the mass of BSA alone (66,430 Da), the mole ratio of
DOTA to BSA was determined for each species.

Based on the intensities of the individual species, the most dominant species (at 69,910 Da with
an intensity of 100%) had a mole ratio of 9 mol DOTA: 1 mol BSA. The mole ratio for all species
ranged from 9 mol DOTA: 1 mol BSA to 86 mol DOTA: 1 mol BSA. This helps to conclude that the
DOTA is conjugating to BSA but producing too many different species.
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The optimal mole fraction for the conjugation reaction is not defined at the current moment. It
is known that there are approximately 60 lysine residues present on bovine serum albumin
meaning that there is a possibility of 60 mol of DOTA to attach to the 60 lysines. However, as
seen in Figure 15, there is a species that has 86 mol of DOTA per mol of BSA. This means that the
DOTA-NHS ester potentially could have reacted with other nucleophilic groups present on the
protein. Additionally, it is not ideal to have all 60 mol of lysine to be conjugated to the DOTA as
it could hinder the protein from future reactions (e.g., capturing the biomarker).

3.3 Results and Discussion – Conjugation Analysis via SDS-PAGE
A complementary SDS-PAGE analysis was done to confirm that conjugation was occurring. The
result of this analysis can be seen in Figure 16.

Figure 16. The gel from the SDS-PAGE results. Well 1 contained the molecular weight standard for comparison.
Well A contained BSA alone from 11/3 unprocessed. Well B contained BSA alone from 10/29 unprocessed. Well
C contained BSA alone from 10/29 processed. Wells D and E contained DOTA-conjugated BSA samples.
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As seen on the gel, the mass of the BSA alone showed up around the molecular weight standard
band of 66 kDa which was expected. Similar to the results seen on the IM-TOF, the comparison
of the BSA alone prepared on different dates showed no significant differences. No significant
difference was seen between the processed (underwent the reaction conditions) versus
unprocessed BSA alone samples as well. This helps to confirm that the BSA is stable under the
reaction conditions and when prepared earlier.

The conjugated species showed a result different than what was expected. Theoretically, it was
expected that if 30 mol of DOTA were added to 1 mol of protein then, per one mol of protein,
multiple DOTA will attach causing a shift in the mass and be represented on the gel as seen in
Figure 17.

Figure 17. Theoretical/ expected conjugation of DOTA to 1 mol of BSA. A significant mass shift is seen in the gel
of the SDS-PAGE.

However, what is being seen on the gel is a larger band around 66 kDa instead of seeing a
significant mass shift. This could mean that instead of all 30 mol of DOTA conjugating to 1 mol
of protein, we are seeing various different species: 1 mol of protein with 3 mol of DOTA, 1 mol of
protein with 1 mol of DOTA, etc. This observation can be seen visually in Figure 18.
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Figure 18. Experimental observation of the conjugation of DOTA to BSA. No significant mass shift is observed
but instead the presence of a wider band at 66 kDa.

Comparing to the molecular weight standards at 97 kDa and 66 kDa, the DOTA-BSA sample
extends over that range with a darker broad band at 66 kDa. This result can also be seen in the
IM-TOF results; there is a large range of mole ratios of DOTA-BSA where some species had 9, 20,
and 50 mol of DOTA attached. Therefore, it could be explained that the mass shift is not
significant enough to see in the SDS-PAGE because multiple species are occurring. However, since
SDS-PAGE completely denatures the protein resulting in a long chain of residues, the addition of
DOTA would not change the length of the SDS-denatured chains – the DOTA conjugates to the
residues and does not add to the end of the chain. This could also be why a significant shift is not
seen; although the addition of DOTA changes the weight of the protein, the separation technique
of SDS-PAGE is based on length, making it not as useful for the intended qualitative analysis.
Although the separation is based on length, it may still be helpful to use different SDS-PAGE gels
at different acrylamide concentrations that focus on separating proteins about 60-70 kDa in size
to enhance the resolution of the DOTA-BSA species. Additionally, this technique can continue to
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be used to ensure that the DOTA-conjugation reaction is not causing the BSA to degrade or
fragment.

3.4 Conclusion
In summary, it was determined that (1) BSA is not decomposed by the reaction conditions, (2)
BSA can be stored for at least up to 4 weeks (at 4°C in the dark), and (3) conjugation is occurring
based on the clear differences between the mass spectra of BSA alone and DOTA-BSA. Multiple
DOTA-BSA conjugated species were found ranging from 9 mol DOTA per mol of BSA to 85 mol
DOTA per mol BSA. The SDS-PAGE analysis also represented this range of mole ratios. The most
abundant species was the DOTA-BSA with a ratio of 9:1 with a molecular weight of 69,910 Da.

In order to minimize the number of species that form, it is recommended to first optimize the
reaction conditions (time, pH, temperature, molar equivalence). Optimizing the reaction
conditions may increase the moles of DOTA attached per moles of BSA giving it more time to
react, for example, or changing the pH. While the reaction conditions are changing, the effect of
these changes, such as on the structural stability of BSA, must also be checked. Another
recommendation would be to try polymeric DOTA. Using polymeric DOTA may increase the
number of DOTA conjugating to the protein which could increase the number of lanthanides
labeled to the protein. This ultimately increases the sensitivity allowing for an even more
sensitive method that would increase the chance of being able to detect low abundance, low
concentrated proteins.
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Chapter 4 – Conclusion and Future Recommendations
4.0 Conclusion
This project had the objective to evaluate a single quadrupole inductively coupled plasma mass
spectrometer for the analysis and absolute quantitation of proteins. This was part of a larger
project that seeks to take advantage of the wider dynamic range and sensitivity of plasma-based
mass spectrometric techniques for the absolute quantitation of low abundance proteins. Most
laboratories have access to this low-resolution (less accurate) instrument, allowing this method
to have the potential to be used almost anywhere. The central objective of this study was to
establish the analytical utility of a low resolution ICP-MS for absolute quantitation of proteins.

The first component of this research project hoped to establish and validate a less sensitive mass
analyzer for lanthanide analysis in solution. This component investigated the analysis of
lanthanides via ICP-MS in both 2% nitric acid (the common ICP-MS solvent) and a 0.1 M acetic
acid buffer. It was found that the ICP-MS is a suitable instrument for the analysis of lanthanides
in solution. Commonly investigated analytical figures of merit were used as parameters to
determine the suitability of the ICP-MS such as detection limit, quantitation limit, sensitivity, and
linearity (R2). In both solvents the detection and quantitation limits were in parts per trillion
meaning that the ICP-MS would be capable of detecting and measuring lanthanides with as low
of a concentration of 10-12 (fg/L). Additionally, the sensitivities of the ICP-MS were comparable
to the most sensitive instrument used in proteomic analysis (Q-q-Q), especially when using nitric
acid as a solvent, and were almost 1000 times better than all other instruments. This is helpful in
indicating that the ICP-MS would be capable of measuring proteins found in a cell that are low in
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concentration and low in abundance. The background equivalent concentration (BEC) was the
determining factor to determine which solvent and which gas mode was optimal for analysis due
to its ability to provide a practical limit of quantitation. The nitric acid solvent proved to be the
most optimal solvent since the acetic acid buffer had higher background equivalent
concentrations. Despite this, the acetic acid buffer still had suitable performance characteristics,
however, it would be best to continue searching for other acid buffers / organic solvents that
could have even greater performance comparable to the nitric acid solvent.

The second component of this research project hoped to establish and validate the conjugation
reaction of DOTA to the protein. This investigation was carried out by running the intended
conjugation reaction with bovine serum albumin (BSA) and a DOTA-NHS ester on an ion mobility
time of flight mass spectrometer. A complementary SDS-PAGE was also run in order to confirm
conjugation. It was found that conjugation was occurring, based on the comparison of generated
mass spectra between BSA without the addition of DOTA, and BSA with the addition of DOTA.
Although conjugation is occurring, it is apparent that multiple DOTA-BSA conjugated species are
present ranging from a DOTA: BSA mol ratio from 9:1 to 85:1. The most abundant species was
found was the DOTA-BSA with a ratio of 9:1 having a molecular weight of 69,910 Da. The SDSPAGE analysis showed similar results where a larger band around the molecular weight standard
at 66 kDa was formed validating the possibility of multiple species existing within a small mass
range.
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4.1 Future Directions/ Recommendations
Although the establishment of lanthanide analysis and conjugation was accomplished in this
thesis, the bulk of the project has many more investigations and experiment that need to be done
before this method can established on actual antibodies in cells.

It is recommended that the first steps to take are to (1) investigate more acid buffers for the
analysis of lanthanides suitable to run on a liquid chromatography column and (2) optimize the
conjugation reaction.

Esteban-Fernandez et al.11 used a mobile phase containing acetonitrile and formic acid and ran a
gradient elution on HPLC-ICP-MS when analyzing peptides labeled with europium.8 Patel et al.
used two mobile phases with (A) containing 0.05% formic acid and water and (B) containing
0.05% formic acid and acetonitrile. Patel et al. ran a gradient elution via LC-ICP-MS to analyze
DTPA conjugated proteins labeled with europium and terbium.23 It may be beneficial to use
something similar to this mobile phase as the solvent. A formic acid buffer may be a potential
solvent that could provide sensitive analysis comparable to the nitric acid solvent. Once a suitable
solvent is found, the next component would be to run all calibration standards and all elements
investigated in this paper via liquid chromatography coupled to the ICP-MS.

For the conjugation reaction, there are multiple factors that must be optimized before moving
on to the labeling step of the total protein quantification scheme. These parameters include pH,
temperature, time, and molar equivalence. In terms of pH, it is recommended to run the reaction
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at a pH of around 8 to ensure that the lysine functional groups are the main target for the DOTANHS ester compared to other -NH2 groups. This would help make a better estimate of the mol
ratio of DOTA:BSA if it the reaction favors conjugation to one specific -NH2 group.21,22 For the
time optimization, a time trial is recommended – the reaction should be run for different lengths
of time and analyzed via IM-TOF and SDS-PAGE to compare the mol ratio of conjugation. The
experiment in this thesis ran the reaction for 60 minutes, so it is recommended the time trial run
the reaction under 60 minutes and for longer than 60 minutes (e.g., 30 min, 120 min, 180 min,
overnight). In terms of temperature, the reaction should be compared by running it in this
investigation (4°C) and at room temperature. This is recommended by the Thermo Scientific
Crosslinking Technology guide.21 Lastly, for molar equivalence, the current investigation ran the
reaction by adding 500x molar equivalence of DOTA. It is unknown what an optimal molar
equivalence would be, but this may be important in optimal conjugation – a higher molar
equivalence vs. a lower molar equivalence. These should all be ran on both the IM-TOF for
stoichiometry and mol ratios and an SDS-PAGE for complementary confirmation.
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Appendix A
Table A1. Praseodymium (Pr3+) analytical figures of merit in the three different gas modes in 2% HNO3 (v/v)
Pr in No Gas Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity*
(m, 1/ppb)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.039

1.334

4.447

0.649

0.9639

0.1- 1.0

0.035

1.495

4.983

0.727

0.9999

1.0 -10

0.048

1.085

3.618

0.528

0.9925

Pr in Helium Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m, 1/ppb)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.047

0.672

2.241

0.464

0.9996

0.1- 1.0

0.050

0.634

2.114

0.438

0.9989

1.0 -10

0.047

0.672

2.242

0.464

0.9994

Pr in High Efficiency Helium Mode Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m,1/ppb)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.050

11.843

39.477

7.558

0.9761

0.1- 1.0

0.060

9.753

32.509

6.224

0.9967

1.0 -10

0.059

9.888

32.960

6.310

0.9996

Table A2. Praseodymium (Pr3+) analytical figures of merit in the three gas modes in 0.1 M acetic acid buffer
Pr in No Gas Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity*
(m, 1/ppb)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.041

19.259

64.195

206.385

0.9853

0.1- 1.0

0.025

30.852

102.839

350.797

0.9978

1.0 -10

0.014

55.980

186.601

273.805

0.9887

Pr in Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m, 1/ppb)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.022

12.788

42.627

369.102

0.9896

0.1- 1.0

0.017

16.800

56.000

472.997

0.9876
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1.0 -10

0.013

22.106

73.688

276.510

0.9970

Pr in High Efficiency Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m,1/ppb)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.042

129.877

432.923

350.144

0.9901

0.1- 1.0

0.029

186.629

622.098

502.235

0.9926

1.0 -10

0.021

260.360

867.865

402.200

0.9979

Table A3. Neodymium (Nd3+) analytical figures of merit in the three different gas modes in 2% HNO3 (v/v)
Nd in No Gas Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.007

0.488

1.628

0.779

0.9683

0.1- 1.0

0.006

0.551

1.835

0.879

0.9989

1.0 -10

0.008

0.403

1.345

0.644

0.9911

Nd in Helium Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.008

0.881

2.937

2.442

0.9999

0.1- 1.0

0.008

0.864

2.881

2.395

0.9997

1.0 -10

0.008

0.881

2.938

2.442

0.9999

Nd in High Efficiency Helium Mode (HEHe) in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.008

67.944

226.480

20.990

0.9738

0.1- 1.0

0.010

55.431

184.769

17.125

0.9916

1.0 -10

0.010

56.343

187.811

17.407

0.9999

Table A4. Neodymium (Nd3+) analytical figures of merit in the three gas modes in 0.1 M acetic acid buffer
Nd in No Gas Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.001

38.803

129.342

118.832

0.9983

0.1- 1.0

0.003

14.404

48.014

28.010

0.9841
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1.0 -10

0.002

17.600

58.667

129.137

0.9992

Nd in Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.001

12.047

40.157

108.053

0.9829

0.1- 1.0

0.002

6.083

20.277

29.723

0.9940

1.0 -10

0.002

5.916

19.719

21.062

0.9999

Nd in High Efficiency Helium Mode (HEHe) in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.006

77.185

257.284

37.154

0.8875

0.1- 1.0

0.003

150.109

500.365

128.165

0.9967

1.0 -10

0.004

123.013

410.044

-76.038

0.9992

Table A5. Samarium (Sm3+) analytical figures of merit in the three different gas modes in 2% HNO3 (v/v)
Sm in No Gas Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

BEC (ppt)

R2

0.01 - 0.1

0.006

5.992

19.972

1.608

0.9685

0.1- 1.0

0.006

6.780

22.600

1.819

0.9999

1.0 -10

0.008

4.944

16.479

1.327

0.9924

Sm in Helium Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

BEC (ppt)

R2

0.01 - 0.1

0.007

1.419

4.732

0.939

0.9999

0.1- 1.0

0.008

1.375

4.585

0.910

0.9988

1.0 -10

0.007

1.420

4.733

0.939

0.9999

Sm in High Efficiency Helium Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.008

32.440

108.132

159.790

0.9773

0.1- 1.0

0.010

24.552

81.839

12.094

0.9862

1.0 -10

0.009

27.200

90.667

13.398

0.9993
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The following table (Table 9) represents the analytical figures of merit for the lanthanide
samarium in the three different gas modes prepared in 0.1 M acetic acid buffer.

Table A6. Samarium (Sm3+) analytical figures of merit for the three gas modes in 0.1 M acetic acid buffer
Sm in No Gas Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.050

5.985

19.951

32.113

0.9907

0.1- 1.0

0.005

65.639

218.798

490.133

0.9649

1.0 -10

0.005

60.313

201.045

324.738

0.9995

Sm in Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.039

3.700

12.335

40.199

0.9837

0.1- 1.0

0.003

44.825

149.417

727.968

0.8671

1.0 -10

0.004

34.572

115.239

395.713

0.9942

Sm in High Efficiency Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.072

10.882

36.274

43.885

0.9719

0.1- 1.0

0.009

86.049

286.830

506.410

0.9539

1.0 -10

0.007

105.487

351.623

449.797

0.9945

Table A7. Gadolinium (Gd3+) analytical figures of merit in all three gas modes in 2% HNO3 (v/v)
Gd in No Gas Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

0.01 - 0.1

0.007

0.913

3.042

0.563

0.9669

0.1- 1.0

0.008

0.770

2.568

0.475

0.9933

1.0 -10

0.009

0.749

2.496

0.462

0.9914

Gd in Helium Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

0.01 - 0.1

0.009

1.654

5.512

2.074

0.9991
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0.1- 1.0

0.009

1.622

5.405

2.034

0.9989

1.0 -10

0.009

1.655

5.518

2.076

0.9999

Gd in High Efficiency Helium Mode in Nitric Acid
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

0.01 - 0.1

0.009

61.133

203.777

32.075

0.9810

0.1- 1.0

0.010

50.771

169.236

26.638

0.9956

1.0 -10

0.010

52.053

173.509

27.311

1.0000

Table A8. Gadolinium (Gd3+) analytical figures of merit for the three gas modes in 0.1 M acetic acid buffer
Gd in No Gas Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.022

13.037

43.457

81.415

0.9829

0.1- 1.0

0.009

30.251

100.837

264.558

0.9949

1.0 -10

0.003

106.754

355.848

227.231

0.9927

Gd in Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.015

5.698

18.993

120.269

0.9615

0.1- 1.0

0.007

12.827

42.758

349.382

0.9963

1.0 -10

0.003

34.000

113.334

484.190

0.9947

Gd in High Efficiency Helium Mode in Acetic Acid Buffer
Concentration
Range (ppb)

Sensitivity
(m)

Detection
Limit (ppt)

Quantitation
Limit (ppt)

Background
Equivalent
Conc. (ppt)

R2

0.01 - 0.1

0.020

91.216

304.052

200.633

0.9367

0.1- 1.0

0.013

140.709

469.031

352.546

0.9997

1.0 -10

0.005

388.380

1294.599

851.414

0.9990
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